Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-30

Clinical Trial Update: Hydrogen Sulfide and Peripheral Arterial Disease

View source ↗

Summary

This update notes the completion of a clinical trial studying hydrogen sulfide for peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrogen sulfide (hydrogen sulfide)

Snippet

Sponsor: Louisiana State University Health Sciences Center Shreveport | Conditions: Peripheral Arterial Disease | Status: COMPLETED